JG
IMMU

Joel Greenblatt’s Immunomedics Inc IMMU Stock Holding History

Joel Greenblatt’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-14,876
Closed -$310K – 1147
2018
Q3 		$310K Sell
14,876
-9,005
-38% -$213K ﹤0.01% 828
2018
Q2 		$565K Buy
23,881
+10,517
+79% +$211K 0.01% 675
2018
Q1 		$195K Hold
13,364
– – ﹤0.01% 894
2017
Q4 		$216K Sell
13,364
-355,931
-96% -$4.2M ﹤0.01% 876
2017
Q3 		$5.16M Buy
369,295
+98,799
+37% +$985K 0.08% 352
2017
Q2 		$2.39M Buy
+270,496
New +$1.9M 0.03% 488

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Joel Greenblatt's IMMU Position: Q4 2018 in Review

Joel Greenblatt sold out of Immunomedics Inc (IMMU) in Q4 2018, closing a stake of 14,876 shares — an estimated $310K sold.

Joel Greenblatt first reported a position in IMMU in Q2 2017 and held it in 6 quarters. The position peaked at $5.16M in Q3 2017. 205 funds tracked by Wall St. Rank hold IMMU as of Q4 2018.

  • Joel Greenblatt reported no remaining Immunomedics Inc position as of Q4 2018 after selling out during the quarter.
  • Joel Greenblatt sold 14,876 Immunomedics Inc shares in Q4 2018, an estimated $310K.
  • Joel Greenblatt first reported a position in Immunomedics Inc in Q2 2017 and held it in 6 quarters.
  • Joel Greenblatt's Immunomedics Inc position peaked at $5.16M in Q3 2017.
  • 205 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2018.

Based on Gotham Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.